Why the study?
PTMC is the recommended treatment for severe mitral stenosis with favourable morphology, but outcomes across subgroups of age, gender, and heart rhythm needed evaluation.
Does the success rate of percutaneous transvenous mitral commisurotomy differ according to age, gender, and heart rhythm in patients with severe mitral stenosis?
Does the success rate of percutaneous transvenous mitral commisurotomy differ according to age, gender, and heart rhythm in patients with severe mitral stenosis?
PTMC is highly successful (86%) in treating severe mitral stenosis, with outcomes that are consistent regardless of patient age, gender, or the presence of atrial fibrillation.
PTMC procedural success was similar across age, gender, and rhythm in this single-center cohort; leaves open generalizability to other populations.
Background: Percutaneous transvenous mitral commisurotomy (PTMC) is the recommended treatment in the severe mitral stenosis with mitral valve area ≤ 1.5 sq. cm and favourable mitral valve morphology without Left atrium (LA) clot. Methods: A retrospective study done for one year among all the patients who had undergone PTMC in 2016. Successful PTMC was defined as increase in Mitral valve area (MVA) more than or equal to 1.5 sq. cm or increase in area by more than 50% from baseline. Data was analyze using SPSS-20. Results: Three hundred thirty sex patients with mean age 34.08 ±12.0 of which male were 97 ( 26.9 %.) and female were 239 (71.1 %). There were 225 (67%) sinus rhythm (SR) and 111 (33%) atrial fibrillation (AF). The median Pre PTMC area and Left atrial (LA) Pressure were 0.9 sq cm and 24 mmHg respectively. The overall success of PTMC was in 289 (86%). The successful outcome in age categories less than 20 years, 20-40, 40-60 and more than 60 years in order are 39 (83%), 174 (86.6%), 71 (86.6%) and 5 (83.3 %). Success for male was 84 (86.6%) and in female 205(86%). Success percentage in SR was 192 (86%) and in atrial fibrillation was 97 (87.4%). Conclusion: The outcome of PTMC in terms of change in mitral valve area was similar to the different age categories, gender and presence and absence of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Dhungel et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: